Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Stephens

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2025
Multi-parametric [<sup>18</sup>F]PI-2620 tau PET/MRI for the phenotyping of different Alzheimer's disease variantsMichael Rullmann, Dylan Henssen, Juliana T Melasch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2019
Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of <sup>18</sup>F-PI-2620 PET for the Assessment of Tau Deposits in the Human BrainSantiago Bullich, Olivier Barret, Cristian Constantinescu, et al.
Biomolecules|March 25, 2022
Multicenter <sup>18</sup>F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's DiseaseMichael Rullmann, Matthias Brendel, Matthias L Schroeter, et al.
Alzheimer'S Research & Therapy|November 28, 2024
Head-to-head comparison of tau PET tracers [<sup>18</sup>F]PI-2620 and [<sup>18</sup>F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohortMatteo Tonietto, Oscar Sotolongo-Grau, Núria Roé-Vellvé, et al.
EJNMMI Research|January 9, 2019
A phase 1, first-in-human study of <sup>18</sup>F-GP1 positron emission tomography for imaging acute arterial thrombosisSun Young Chae, Tae-Won Kwon, Soyoung Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Clinical Evaluation of (4S)-4-(3-[<sup>18</sup>F]Fluoropropyl)-L-glutamate (<sup>18</sup>F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate CancerSonya Youngju Park, Sae Jung Na, Meena Kumar, et al.
The Lancet. Oncology|March 22, 2015
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 studyMartin Fassnacht, Alfredo Berruti, Eric Baudin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2016
Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 StudyJohn Seibyl, Ana M Catafau, Henryk Barthel, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2021
<i>In Vivo</i> Thrombosis Imaging in Patients Recovering from COVID-19 and Pulmonary EmbolismRong Bing, Jack P M Andrews, Michelle C Williams, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2025
Developing a novel reference region for [<sup>18</sup>F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathiesLukas Frontzkowski, Johannes Gnörich, Mattes Gross, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|February 12, 2025
Multi-parametric [<sup>18</sup>F]PI-2620 tau PET/MRI for the phenotyping of different Alzheimer's disease variantsMichael Rullmann, Dylan Henssen, Juliana T Melasch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 13, 2019
Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of <sup>18</sup>F-PI-2620 PET for the Assessment of Tau Deposits in the Human BrainSantiago Bullich, Olivier Barret, Cristian Constantinescu, et al.
Biomolecules|March 25, 2022
Multicenter <sup>18</sup>F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's DiseaseMichael Rullmann, Matthias Brendel, Matthias L Schroeter, et al.
Alzheimer'S Research & Therapy|November 28, 2024
Head-to-head comparison of tau PET tracers [<sup>18</sup>F]PI-2620 and [<sup>18</sup>F]RO948 in non-demented individuals with brain amyloid deposition: the TAU-PET FACEHBI cohortMatteo Tonietto, Oscar Sotolongo-Grau, Núria Roé-Vellvé, et al.
EJNMMI Research|January 9, 2019
A phase 1, first-in-human study of <sup>18</sup>F-GP1 positron emission tomography for imaging acute arterial thrombosisSun Young Chae, Tae-Won Kwon, Soyoung Jin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
Clinical Evaluation of (4S)-4-(3-[<sup>18</sup>F]Fluoropropyl)-L-glutamate (<sup>18</sup>F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate CancerSonya Youngju Park, Sae Jung Na, Meena Kumar, et al.
The Lancet. Oncology|March 22, 2015
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 studyMartin Fassnacht, Alfredo Berruti, Eric Baudin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 30, 2016
Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 StudyJohn Seibyl, Ana M Catafau, Henryk Barthel, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2021
<i>In Vivo</i> Thrombosis Imaging in Patients Recovering from COVID-19 and Pulmonary EmbolismRong Bing, Jack P M Andrews, Michelle C Williams, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2025
Developing a novel reference region for [<sup>18</sup>F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathiesLukas Frontzkowski, Johannes Gnörich, Mattes Gross, et al.
Pageof 8